The role of platelet-derived ADP and ATP in promoting pancreatic cancer cell survival and gemcitabine resistance

QR Code

The role of platelet-derived ADP and ATP in promoting pancreatic cancer cell survival and gemcitabine resistance

Platelets have been demonstrated to be vital in cancer epithelial-mesenchymal transition (EMT), an important step in metastasis. Markers of EMT are associated with chemotherapy resistance. However, the association between the development of chemoresistance, EMT, and the contribution of platelets to...

Full description

Bibliographic Details
Main Authors:	Elaskalani, Omar, Falasca, Marco, Moran, N., Berndt, Michael, Metharom, Pat
Format:	Journal Article
Published:	MDPI AG 2017
Online Access:	http://hdl.handle.net/20.500.11937/57747

Similar Items

Targeting platelets for the treatment of cancer
by: Elaskalani, Omar, et al.
Published: (2017)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)

The functional role of platelets in the regulation of angiogenesis
by: Walsh, T., et al.
Published: (2015)

Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
by: Adamska, Aleksandra, et al.
Published: (2018)

Platelets — Allies of Tumour Cells
by: Metharom, Pat, et al.
Published: (2015)

Pancreatic cancer-induced neutrophil extracellular traps: A potential contributor to cancer-associated thrombosis
by: Razak, N., et al.
Published: (2017)

Extracellular DNA and histones are dispensable for neutrophil extracellular trap-induced aggregation of human washed platelets
by: Elaskalani, O., et al.
Published: (2018)

GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
by: Ferro, R., et al.
Published: (2018)

GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
by: Ferro, Riccardo, et al.
Published: (2018)

ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
by: Adamska, A., et al.
Published: (2018)

Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones
by: Elaskalani, O., et al.
Published: (2018)

A brief history of blood platelets: A personal view
by: Berndt, Michael, et al.
Published: (2017)

PYK2 is prerequisite for GPVI-induced platelet ROS production, but not aggregation
by: Walsh, T., et al.
Published: (2011)

The role of NADPH oxidase (NOX) 1 and 2 in GPVI-dependent platelet activation and thrombus formation
by: Walsh, T., et al.
Published: (2013)

Bile salt chenodeoxycholate suppresses normal platelet functions through cyclic amp activation pathway
by: Metharom, Pat, et al.
Published: (2015)

Diet and pancreatic cancer prevention
by: Casari, I., et al.
Published: (2015)

The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation
by: Walsh, T., et al.
Published: (2014)

The History of Armand Trousseau and Cancer-Associated Thrombosis
by: Metharom, Pat, et al.
Published: (2019)

Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
by: Middleton, Gary, et al.
Published: (2017)

Platelet-cancer Crosstalk: Mechanisms and Therapeutic Implications
by: Elaskalani, Omar
Published: (2019)

Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIba.
by: Carrim, N., et al.
Published: (2015)

Role of Focal Adhesion Tyrosine Kinases in GPVI-Dependent Platelet Activation and Reactive Oxygen Species Formation
by: Carrim, N., et al.
Published: (2014)

Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
by: Elaskalani, O., et al.
Published: (2017)

Impact of Gemcitabine Chemotherapy and 3-Dimensional Conformal Radiation Therapy/5-Fluorouracil on Quality of life of patients Managed for Pancreatic Cancer
by: Short, Michelle, et al.
Published: (2013)

Emerging role of the KRAS-PDK1 axis in pancreatic cancer
by: Ferro, R., et al.
Published: (2014)

Double major ADP programme at SEGi
Published: (2010)

Pancreatic ductal adenocarcinoma: Current and evolving therapies
by: Adamska, A., et al.
Published: (2017)

Pancreatic cancer: Current research and future directions
by: Falasca, Marco, et al.
Published: (2016)

KDU student achieves dream, thanks to ADP
Published: (2010)

Investigating the mechanisms of activation and action of phosphoinositide 3-kinase C2 alpha in pancreatic beta cells
by: Mazza, S., et al.
Published: (2013)

Liver-mediated shedding of platelet GPVI
by: Berndt, Michael, et al.
Published: (2016)

Microparticles facilitate neutrophil platelet crosstalk
by: Andrews, R., et al.
Published: (2008)

Systems biology meets platelet biology
by: Berndt, Michael, et al.
Published: (2008)

Platelet-VWF complexes get the chop
by: Berndt, Michael, et al.
Published: (2008)

Platelet Receptor Shedding
by: Gardiner, E., et al.
Published: (2012)

Benzimidazole derivatives as potential dual inhibitors for poly (adp-ribose) polymerase-1 and dihydroorotate dehydrogenase / Iskandar Abdullah
by: Iskandar, Abdullah
Published: (2015)

Platelet adhesion: A game of catch and release
by: Andrews, R., et al.
Published: (2008)

Major Platelet Glycoproteins: GPIB-IX-V
by: Berndt, Michael, et al.
Published: (2013)

Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells
by: Egan, K., et al.
Published: (2011)

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
by: Middleton, Gary, et al.
Published: (2014)